Lexeo Therapeutics, Inc.
Tobin Schilke (Director) reports LXEO insider transactions
About this filing
Lexeo Therapeutics, Inc. (LXEO) filed Form 3 (initial insider holdings) with the SEC on Nov 17, 2026.
Key facts
- Insider
- Tobin Schilke · Director
No transactions reported; holdings only.
More LXEO filings
- 4
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
- SC 13G/A
Filed Nov 16, 2026
- SC 13G/A
Filed Nov 16, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.